BlackRock’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Hold |
703,798
| – | – | ﹤0.01% | 4584 |
|
|
2025
Q1 | $201K | Hold |
703,798
| – | – | ﹤0.01% | 4553 |
|
|
2024
Q4 | $236K | Hold |
703,798
| – | – | ﹤0.01% | 4533 |
|
|
2024
Q3 | $300K | Hold |
703,798
| – | – | ﹤0.01% | 4391 |
|
|
2024
Q2 | $305K | Sell |
703,798
-11,642
| -2% | -$5.05K | ﹤0.01% | 4404 |
|
|
2024
Q1 | $286K | Sell |
715,440
-2,444
| -0.3% | -$978 | ﹤0.01% | 4455 |
|
|
2023
Q4 | $201K | Hold |
717,884
| – | – | ﹤0.01% | 4559 |
|
|
2023
Q3 | $258K | Sell |
717,884
-37,902
| -5% | -$13.6K | ﹤0.01% | 4545 |
|
|
2023
Q2 | $236K | Sell |
755,786
-76
| -0% | -$24 | ﹤0.01% | 4605 |
|
|
2023
Q1 | $257K | Hold |
755,862
| – | – | ﹤0.01% | 4624 |
|
|
2022
Q4 | $240K | Buy |
755,862
+11,642
| +2% | +$3.7K | ﹤0.01% | 4716 |
|
|
2022
Q3 | $321K | Buy |
744,220
+56
| +0% | +$24 | ﹤0.01% | 4759 |
|
|
2022
Q2 | $394K | Sell |
744,164
-114,622
| -13% | -$60.7K | ﹤0.01% | 4759 |
|
|
2022
Q1 | $815K | Sell |
858,786
-2,428
| -0.3% | -$2.3K | ﹤0.01% | 4645 |
|
|
2021
Q4 | $842K | Buy |
861,214
+18,931
| +2% | +$18.5K | ﹤0.01% | 4651 |
|
|
2021
Q3 | $1.25M | Sell |
842,283
-972
| -0.1% | -$1.44K | ﹤0.01% | 4435 |
|
|
2021
Q2 | $1.38M | Sell |
843,255
-67,711
| -7% | -$111K | ﹤0.01% | 4347 |
|
|
2021
Q1 | $1.63M | Buy |
910,966
+1,744
| +0.2% | +$3.12K | ﹤0.01% | 4291 |
|
|
2020
Q4 | $1.42M | Buy |
909,222
+881,396
| +3,168% | +$1.37M | ﹤0.01% | 4054 |
|
|
2020
Q3 | $29K | Buy |
27,826
+12
| +0% | +$13 | ﹤0.01% | 4566 |
|
|
2020
Q2 | $17K | Sell |
27,814
-66,730
| -71% | -$40.8K | ﹤0.01% | 4636 |
|
|
2020
Q1 | $47K | Buy |
94,544
+60,290
| +176% | +$30K | ﹤0.01% | 4411 |
|
|
2019
Q4 | $22K | Buy |
34,254
+26,774
| +358% | +$17.2K | ﹤0.01% | 4580 |
|
|
2019
Q3 | $7K | Buy |
+7,480
| New | +$7K | ﹤0.01% | 4696 |
|